Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Enhancing the removal of aggregate-prone toxic proteins is a rational therapeutic strategy for a number of neurodegenerative diseases, especially Huntington’s disease and various spinocerebellar ataxias. Ideally, such approaches should preferentially clear the mutant/misfolded species, while having minimal impact on the stability of wild-type/normally-folded proteins. Furthermore, activation of both ubiquitin-proteasome and autophagy-lysosome routes may be advantageous, as this would allow effective clearance of both monomeric and oligomeric species, the latter which are inaccessible to the proteasome. Here we find that compounds that activate the D1 ATPase activity of VCP/p97 fulfill these requirements. Such effects are seen with small molecule VCP activators like SMER28, which activate autophagosome biogenesis by enhancing interactions of PI3K complex components to increase PI(3)P production, and also accelerate VCP-dependent proteasomal clearance of such substrates. Thus, this mode of VCP activation may be a very attractive target for many neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the protein is delivered to lysosomes via autophagy, the lysosome-sensitive Ypet protein is degraded, relieving fluorescence resonance energy transfer inhibition of the blue TOLLES signal (as TOLLES is relatively resistant to lysosomal proteolysis).43”
From USP7 protects TFEB from proteasome-mediated degradation (2024) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bruderer, R., Bernhardt, O. M., Gandhi, T., Miladinović, S. M., Cheng, L.-Y., Messner, S., Ehrenberger, T., Zanotelli, V., Butscheid, Y., Escher, C., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.044305 · Cited by 1,238
Self-citationHeras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.019 · Cited by 1,091
Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies
Ciechanover, A., & Kwon, Y. T. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.117 · Cited by 898
Dieterich, D. C., Link, A. J., Graumann, J., Tirrell, D. A., & Schuman, E. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601637103 · Cited by 874
Eukaryotic Stress Granules Are Cleared by Autophagy and Cdc48/VCP Function
Buchan, J. R., Kolaitis, R.-M., Taylor, J. P., & Parker, R. (2013) · Cell · doi:10.1016/j.cell.2013.05.037 · Cited by 737
mProphet: automated data processing and statistical validation for large-scale SRM experiments
Reiter, L., Rinner, O., Picotti, P., Hüttenhain, R., Beck, M., Brusniak, M.-Y., Hengartner, M. O., & Aebersold, R. (2011) · Nature Methods · doi:10.1038/nmeth.1584 · Cited by 532
Self-citationValosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
Ju, J.-S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., & Weihl, C. C. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908115 · Cited by 494
Myeku, N., Clelland, C. L., Emrani, S., Kukushkin, N. V., Yu, W. H., Goldberg, A. L., & Duff, K. E. (2016) · Nature Medicine · doi:10.1038/nm.4011 · Cited by 446
Tresse, E., Salomons, F. A., Vesa, J., Bott, L. C., Kimonis, V., Yao, T.-P., Dantuma, N. P., & Taylor, J. P. (2010) · Autophagy · doi:10.4161/auto.6.2.11014 · Cited by 437
Tian, Y., Chang, J. C., Fan, E. Y., Flajolet, M., & Greengard, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315110110 · Cited by 233
Research works printed but not linked: 68
- Balchin, D., Hayer-Hartl, M. & Hartl, F. U. In vivo aspects of protein folding and quality control. Science 353, aac4354 (2016). · DOI · Paper page
- Dikic, I. Proteasomal and autophagic degradation systems. Annu Rev. Biochem 86, 193–224 (2017). · DOI · Paper page
- Saudou, F. & Humbert, S. The biology of huntingtin. Neuron 89, 910–926 (2016). · DOI · Paper page
- Ashkenazi, A. et al. Polyglutamine tracts regulate autophagy. Autophagy 13, 1613–1614 (2017). · DOI
- Marxreiter, F., Stemick, J. & Kohl, Z. Huntingtin lowering strategies. Int. J. Mol. Sci. 21, https://doi.org/10.3390/ijms21062146 (2020). · DOI
- van den Boom, J. & Meyer, H. VCP/p97-mediated unfolding as a principle in protein homeostasis and signalling. Mol. Cell 69, 182–194 (2018). · DOI · Paper page
- Ye, Y., Tang, W. K., Zhang, T. & Xia, D. A mighty “protein extractor” of the cell: structure and function of the p97/CDC48 ATPase. Front. Mol. Biosci. 4, 39 (2017). · DOI · Paper page
- Chou, T. F. & Deshaies, R. J. Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin-proteasome system. J. Biol. Chem. 286, 16546–16554 (2011). · DOI · Paper page
- Bento, C. F. et al. Mammalian autophagy: how does it work. Annu. Rev. Biochem 85, 685–713 (2016). · DOI · Paper page
- Obara, K., Noda, T., Niimi, K. & Ohsumi, Y. Transport of phosphatidylinositol 3-phosphate into the vacuole via autophagic membranes in Saccharomyces cerevisiae. Genes Cells 13, 537–547 (2008). · DOI · Paper page
- Puri, C., Vicinanza, M. & Rubinsztein, D. C. Phagophores evolve from recycling endosomes. Autophagy 14, 1475–1477 (2018). · doi:10.1080/15548627.2018.1482148
- Mizushima, N., Sugita, H., Yoshimori, T. & Ohsumi, Y. A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J. Biol. Chem. 273, 33889–33892 (1998). · DOI · Paper page
- Kabeya, Y. et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720–5728 (2000). · DOI · Paper page
- Hill, S. M. et al. VCP/p97 regulates Beclin-1-dependent autophagy initiation. Nat. Chem. Biol. https://doi.org/10.1038/s41589-020-00726-x (2021). · DOI
- Rubinsztein, D. C., Codogno, P. & Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Disco. 11, 709–730 (2012). · DOI · Paper page
- Whitmarsh-Everiss, T. & Laraia, L. Small molecule probes for targeting autophagy. Nat. Chem. Biol. 17, 653–664 (2021). · DOI
- Geissler, E. K. The influence of mTOR inhibitors on immunity and the relationship to post-transplant malignancy. Transplant Res. 2, S2 (2013). · DOI
- Sarkar, S. et al. Small molecules enhance autophagy and reduce toxicity in Huntington’s disease models. Nat. Chem. Biol. 3, 331–338 (2007). · DOI · Paper page
- Tian, Y., Bustos, V., Flajolet, M. & Greengard, P. A small-molecule enhancer of autophagy decreases levels of Abeta and APP-CTF via Atg5-dependent autophagy pathway. FASEB J. 25, 1934–1942 (2011). · DOI · Paper page
- Darabi, S. et al. SMER28 attenuates dopaminergic toxicity mediated by 6-hydroxydopamine in the rats via modulating oxidative burdens and autophagy-related parameters. Neurochem. Res. 43, 2313–2323 (2018). · DOI
- Zhong, X., Ouyang, C., Liang, W., Dai, C. & Zhang, W. (2R,6R)-hydroxynorketamine alleviates electroconvulsive shock-induced learning impairment by inhibiting autophagy. Neuropsychiatr. Dis. Treat. 17, 297–304 (2021). · DOI
- VerPlank, J. J. S., Tyrkalska, S. D., Fleming, A., Rubinsztein, D. C. & Goldberg, A. L. cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 117, 14220–14230 (2020). · DOI
- Katayama, H. et al. Visualizing and modulating mitophagy for therapeutic studies of neurodegeneration. Cell 181, 1176–1187.e1116 (2020). · DOI · Paper page
- Trettel, F. et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9, 2799–2809 (2000). · DOI · Paper page
- Shen, D. et al. Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies. Cell Biochem. Biophys. 60, 173–185 (2011). · DOI · Paper page
- Beedham, C., Critchley, D. J. & Rance, D. J. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon. Arch. Biochem. Biophys. 319, 481–490 (1995). · DOI
- Chou, T. F. et al. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains. J. Mol. Biol. 426, 2886–2899 (2014). · DOI
- Lomenick, B. et al. Target identification using drug affinity responsive target stability (DARTS). Proc. Natl. Acad. Sci. USA 106, 21984–21989 (2009). · DOI · Paper page
- DeLaBarre, B. & Brunger, A. T. Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains. Nat. Struct. Biol. 10, 856–863 (2003). · DOI · Paper page
- Magnaghi, P. et al. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat. Chem. Biol. 9, 548–556 (2013). · DOI · Paper page
- Zhou, H. J. et al. Discovery of a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083. J. Med. Chem. 58, 9480–9497 (2015). · DOI · Paper page
- Ye, Y., Meyer, H. H. & Rapoport, T. A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 162, 71–84 (2003). · DOI · Paper page
- Zhang, X. et al. Altered cofactor regulation with disease-associated p97/VCP mutations. Proc. Natl Acad. Sci. USA 112, E1705–1714 (2015).
- Blythe, E. E., Gates, S. N., Deshaies, R. J. & Martin, A. Multisystem proteinopathy mutations in VCP/p97 increase NPLOC4·UFD1L binding and substrate processing. Structure 27, 1820–1829.e1824 (2019). · DOI · Paper page
- Wang, Q., Song, C., Yang, X. & Li, C. C. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP. J. Biol. Chem. 278, 32784–32793 (2003). · DOI
- Piazza, I. et al. A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes. Nat. Commun. 11, 4200 (2020). · DOI · Paper page
- Bago, R. et al. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochem J. 463, 413–427 (2014). · DOI · Paper page
- An, H. et al. TEX264 is an endoplasmic reticulum-resident ATG8-interacting protein critical for ER remodeling during nutrient stress. Mol. Cell 74, 891–908.e810 (2019). · DOI · Paper page
- Chino, H., Hatta, T., Natsume, T. & Mizushima, N. Intrinsically disordered protein TEX264 mediates ER-phagy. Mol. Cell 74, 909–921.e906 (2019). · DOI · Paper page
- Koukourakis, M. I. et al. SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy. Invest. New Drugs 36, 773–781 (2018). · DOI
- Figuerola-Conchas, A. et al. Small-molecule modulators of the ATPase VCP/p97 affect specific p97 cellular functions. ACS Chem. Biol. 15, 243–253 (2020). · DOI
- Marshall, R. S., Hua, Z., Mali, S., McLoughlin, F. & Vierstra, R. D. ATG8-binding uim proteins define a new class of autophagy adaptors and receptors. Cell 177, 766–781 e724 (2019). · DOI · Paper page
- Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M. & Masucci, M. G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18, 538–543 (2000). · DOI · Paper page
- Hänzelmann, P. & Schindelin, H. The interplay of cofactor interactions and post-translational modifications in the regulation of the AAA+ ATPase p97. Front. Mol. Biosci. 4, 21 (2017). · DOI · Paper page
- Bruderer, R. M., Brasseur, C. & Meyer, H. H. The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism. J. Biol. Chem. 279, 49609–49616 (2004). · DOI · Paper page
- Twomey, E. C. et al. Substrate processing by the Cdc48 ATPase complex is initiated by ubiquitin unfolding. Science 365, eaax1033 (2019). · DOI · Paper page
- Aviner, R. The science of puromycin: From studies of ribosome function to applications in biotechnology. Comput. Struct. Biotechnol. J. 18, 1074–1083 (2020). · DOI · Paper page
- Stevenson, J., Huang, E. Y. & Olzmann, J. A. Endoplasmic reticulum-associated degradation and lipid homeostasis. Annu Rev. Nutr. 36, 511–542 (2016). · DOI · Paper page
- Shih, Y. T. & Hsueh, Y. P. VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation. Nat. Commun. 7, 11020 (2016). · DOI
- Song, C., Wang, Q. & Li, C. C. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J. Biol. Chem. 278, 3648–3655 (2003). · DOI · Paper page
- Banerjee, S. et al. 2.3 A resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science 351, 871–875 (2016). · DOI · Paper page
- Olszewski, M. M., Williams, C., Dong, K. C. & Martin, A. The Cdc48 unfoldase prepares well-folded protein substrates for degradation by the 26S proteasome. Commun. Biol. 2, 29 (2019). · DOI · Paper page
- Blythe, E. E., Olson, K. C., Chau, V. & Deshaies, R. J. Ubiquitin- and ATP-dependent unfoldase activity of P97/VCP•NPLOC4•UFD1L is enhanced by a mutation that causes multisystem proteinopathy. Proc. Natl. Acad. Sci. USA 114, E4380–E4388 (2017). · DOI · Paper page
- Bodnar, N. O. & Rapoport, T. A. Molecular mechanism of substrate processing by the Cdc48 ATPase complex. Cell 169, 722–735.e729 (2017). · DOI · Paper page
- Cooney, I. et al. Structure of the Cdc48 segregase in the act of unfolding an authentic substrate. Science 365, 502–505 (2019). · DOI · Paper page
- Halawani, D. et al. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell Biol. 29, 4484–4494 (2009). · DOI · Paper page
- Niwa, H. et al. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J. Biol. Chem. 287, 8561–8570 (2012). · DOI · Paper page
- Meyer, H. J. & Rape, M. Enhanced protein degradation by branched ubiquitin chains. Cell 157, 910–921 (2014). · DOI · Paper page
- Yau, R. G. et al. Assembly and function of heterotypic ubiquitin chains in cell-cycle and protein quality control. Cell 171, 918–933.e920 (2017). · DOI · Paper page
- Doulatov, S. et al. Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci. Transl. Med. 9, https://doi.org/10.1126/scitranslmed.aah5645 (2017). · DOI · Paper page
- Korolchuk, V. I., Mansilla, A., Menzies, F. M. & Rubinsztein, D. C. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol. Cell 33, 517–527 (2009). · DOI · Paper page
- He, R., Peng, J., Yuan, P., Xu, F. & Wei, W. Divergent roles of BECN1 in LC3 lipidation and autophagosomal function. Autophagy 11, 740–747 (2015). · DOI · Paper page
- Bento, C. F., Ashkenazi, A., Jimenez-Sanchez, M. & Rubinsztein, D. C. The Parkinson’s disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway. Nat. Commun. 7, 11803 (2016). · DOI · Paper page
- Hammond, G. R., Schiavo, G. & Irvine, R. F. Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2). Biochem J. 422, 23–35 (2009). · DOI · Paper page
- Liu, J., Xu, Y., Stoleru, D. & Salic, A. Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin. Proc. Natl Acad. Sci. USA 109, 413–418 (2012). · DOI · Paper page
- Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods 6, 275–277 (2009). · DOI · Paper page
- Weith, M. et al. Ubiquitin-independent disassembly by a p97 AAA-ATPase complex drives PP1 holoenzyme formation. Mol. Cell 72, 766–777.e766 (2018). · DOI · Paper page
- Lomenick, B., Jung, G., Wohlschlegel, J. A. & Huang, J. Target identification using drug affinity responsive target stability (DARTS). Curr. Protoc. Chem. Biol. 3, 163–180 (2011). · DOI · Paper page
Cited by
Chu, S., Xie, X., Payan, C., & Stochaj, U. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00639-y · Cited by 58
USP7 protects TFEB from proteasome-mediated degradation
Keshri, S., Vicinanza, M., Takla, M., & Rubinsztein, D. C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114872 · Cited by 13
Self-citation
Metadata
- Authors
- Wrobel, L., Hill, S. M., Djajadikerta, A., Fernandez-Estevez, M., Karabiyik, C., Ashkenazi, A., Barratt, V. J., Stamatakou, E., Gunnarsson, A., Rasmusson, T., Miele, E. W., Beaton, N., Bruderer, R., Feng, Y., Reiter, L., Castaldi, M. P., Jarvis, R., Tan, K., Bürli, R. W., & Rubinsztein, D. C.
- Venue
- Nature Communications
- Published
- 2022-07-16
- Volume
- 13
- Issue
- 1
- ISSN
- 2041-1723
- Cited by
- 49
- References
- 10
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- UK Dementia Research Institute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance. https://app.cochat.ai/papers/10.1038/s41467-022-31905-0
- The paper
- Wrobel, L., Hill, S. M., Djajadikerta, A., Fernandez-Estevez, M., Karabiyik, C., Ashkenazi, A., Barratt, V. J., Stamatakou, E., Gunnarsson, A., Rasmusson, T., Miele, E. W., Beaton, N., Bruderer, R., Feng, Y., Reiter, L., Castaldi, M. P., Jarvis, R., Tan, K., Bürli, R. W., & Rubinsztein, D. C. (2022). Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance. Nature Communications. https://doi.org/10.1038/s41467-022-31905-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.